Document Detail


Cannabinoid system in the skin - a possible target for future therapies in dermatology.
MedLine Citation:
PMID:  19664006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is Delta(9)-tetrahydrocannabinol (Delta(9)-THC), natural psychoactive ingredient of marijuana. However, psychoactive properties of these substances limited their use as approved medicines. Recent discoveries of endogenous cannabinoids (e.g. arachidonoylethanolamide, 2-arachidonoylglycerol or palmithyloethanolamide) and their receptors initiated discussion on the role of cannabinoid system in physiological conditions as well as in various diseases. Based on the current knowledge, it could be stated that cannabinoids are important mediators in the skin, however their role have not been well elucidated yet. In our review, we summarized the current knowledge about the significant role of the cannabinoid system in the cutaneous physiology and pathology, pointing out possible future therapeutic targets.
Authors:
Piotr Kupczyk; Adam Reich; Jacek C Szepietowski
Related Documents :
12575916 - Some aspects of parasitology and immunology in general medicine.
18052856 - Assessing self-management and spirituality practices among older women.
9197736 - The ward sister/charge nurse as 'on site' manager.
22279316 - How to teach evidence-based medicine to urologists.
2558206 - Survey of the use of homeopathic medicine in the uk health system.
7652926 - Progress in traditional chinese medicine.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Experimental dermatology     Volume:  18     ISSN:  1600-0625     ISO Abbreviation:  Exp. Dermatol.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-11     Completed Date:  2009-11-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9301549     Medline TA:  Exp Dermatol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  669-79     Citation Subset:  IM    
Affiliation:
Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cannabinoids / metabolism*,  therapeutic use
Chemistry, Pharmaceutical / methods
Dermatology / methods*
Drug Design
Endocannabinoids / metabolism,  therapeutic use
Humans
Immune System
Keratinocytes / cytology
Models, Biological
Models, Chemical
Signal Transduction
Skin / metabolism*,  physiopathology
Skin Diseases / therapy*
Chemical
Reg. No./Substance:
0/Cannabinoids; 0/Endocannabinoids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Melatonin prevents oxidative stress-mediated mitochondrial permeability transition and death in skel...
Next Document:  Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells.